middle.news
Can 4DMedical’s CT:VQ Disrupt the $1B US Nuclear Lung Scan Market?
1:35am on Monday 2nd of June, 2025 AEST
•
Healthcare
Read Story
Can 4DMedical’s CT:VQ Disrupt the $1B US Nuclear Lung Scan Market?
1:35am on Monday 2nd of June, 2025 AEST
Key Points
CT:VQ submitted for FDA 510(k) clearance
Clinical validation shows equivalence or superiority to nuclear SPECT VQ scans
Targets $1 billion US nuclear lung scan market with non-nuclear alternative
Partnership with Philips and CMS reimbursement support commercialization
Read Story
middle.
Tap to Read
Tap the card to read the full analysis
about
4Dmedical (ASX:4DX)
OPEN ARTICLE